Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

NCT01575652 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2012-04-11

No results posted yet for this study

Summary

The objective of this study was to examine the effects of angiotensin converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients.

Conditions

  • Disorders Associated With Peritoneal Dialysis

Interventions

OTHER

Group using angiotensin converting enzyme inhibitor

Measurement of peritoneal protein loss level with use of ACEIs

OTHER

Group not using angiotensin converting enzyme inhibitor

Measurement of peritoneal protein loss level without usage of ACEIs

Sponsors & Collaborators

  • Turkish Nephrology Association

    lead OTHER

Principal Investigators

  • taner basturk, MD · Sisli Etfal training and Education Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-01-31
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01575652 on ClinicalTrials.gov